TRAMETINIB Drug Patent Profile
✉ Email this page to a colleague
When do Trametinib patents expire, and what generic alternatives are available?
Trametinib is a drug marketed by Hikma and is included in one NDA.
The generic ingredient in TRAMETINIB is trametinib dimethyl sulfoxide. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the trametinib dimethyl sulfoxide profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TRAMETINIB?
- What are the global sales for TRAMETINIB?
- What is Average Wholesale Price for TRAMETINIB?
Summary for TRAMETINIB
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | TRAMETINIB at DailyMed |
US Patents and Regulatory Information for TRAMETINIB
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | TRAMETINIB DIMETHYL SULFOXIDE | trametinib dimethyl sulfoxide | TABLET;ORAL | 219002-001 | Aug 6, 2024 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hikma | TRAMETINIB DIMETHYL SULFOXIDE | trametinib dimethyl sulfoxide | TABLET;ORAL | 219002-002 | Aug 6, 2024 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
